Neogen Corporation Payments to Acquire Productive Assets
Neogen Corporation (NEOG) reported Payments to Acquire Productive Assets of $51.30 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-07-30
- Neogen Corporation payments to acquire productive assets for the quarter ending 2026-05-31 was $4.00M, a 75.16% decline year-over-year.
- Neogen Corporation payments to acquire productive assets for the quarter ending 2026-02-28 was $11.63M, a 64.66% decline year-over-year.
- Neogen Corporation payments to acquire productive assets for the quarter ending 2025-11-30 was $11.67M, a 31.99% decline year-over-year.
- Neogen Corporation payments to acquire productive assets for the quarter ending 2025-08-31 was $24.00M, a 37.55% decline year-over-year.
- Neogen Corporation payments to acquire productive assets for fiscal 2026 was $51.30M, a 50.96% decline from fiscal 2025.
- Neogen Corporation payments to acquire productive assets for fiscal 2025 was $104.60M, a 6.10% decline from fiscal 2024.
- Neogen Corporation payments to acquire productive assets for fiscal 2024 was $111.40M, a 69.41% increase from fiscal 2023.
- Neogen Corporation payments to acquire productive assets for fiscal 2023 was $65.76M, a 169.18% increase from fiscal 2022.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 9 month as first filed | Payments to Acquire Productive Assets 12 month | Payments to Acquire Productive Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-05-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $15.63M derived: sum of 2 quarters · filed 2026-07-30 | $27.30M derived: sum of 3 quarters · filed 2026-07-30 | $51.30M 10-K · filed 2026-07-30 | ||
| 2026-02-28 | $11.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | $23.30M derived: sum of 2 quarters · filed 2026-04-09 | $47.30M 10-Q · filed 2026-04-09 | $63.40M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-11-30 | $11.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $35.67M 10-Q · filed 2026-01-08 | $51.77M derived: sum of 3 quarters · filed 2026-07-30 | $84.68M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-08-31 | $24.00M 10-Q · filed 2025-10-09 | $40.10M derived: sum of 2 quarters · filed 2026-07-30 | $73.01M derived: sum of 3 quarters · filed 2026-07-30 | $90.17M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-05-31 | $16.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $49.01M derived: sum of 2 quarters · filed 2026-07-30 | $66.17M derived: sum of 3 quarters · filed 2026-07-30 | $104.60M 10-K · filed 2026-07-30 | $104.59M 10-K · filed 2025-07-30 | |
| 2025-02-28 | $32.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | $50.07M derived: sum of 2 quarters · filed 2026-04-09 | $88.50M 10-Q · filed 2026-04-09 | $88.46M 10-Q · filed 2025-04-09 | $112.73M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2024-11-30 | $17.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $55.59M 10-Q · filed 2026-01-08 | $79.82M derived: sum of 3 quarters · filed 2026-07-30 | $111.94M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-08-31 | $38.43M 10-Q · filed 2025-10-09 | $62.67M derived: sum of 2 quarters · filed 2026-07-30 | $94.79M derived: sum of 3 quarters · filed 2026-07-30 | $119.20M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-05-31 | $24.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $56.35M derived: sum of 2 quarters · filed 2026-07-30 | $80.77M derived: sum of 3 quarters · filed 2026-07-30 | $111.40M 10-K · filed 2026-07-30 | $111.42M 10-K · filed 2024-07-30 | |
| 2024-02-29 | $32.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-09 | $56.54M derived: sum of 2 quarters · filed 2025-04-09 | $87.17M 10-Q · filed 2025-04-09 | $112.67M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-11-30 | $24.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-15 | $55.05M 10-Q · filed 2025-01-15 | $80.55M derived: sum of 3 quarters · filed 2025-07-30 | $95.70M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-08-31 | $30.63M 10-Q · filed 2024-10-10 | $56.13M derived: sum of 2 quarters · filed 2025-07-30 | $71.28M derived: sum of 3 quarters · filed 2025-07-30 | $83.39M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-05-31 | $25.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | $40.66M derived: sum of 2 quarters · filed 2025-07-30 | $52.76M derived: sum of 3 quarters · filed 2025-07-30 | $65.76M 10-K · filed 2025-07-30 | ||
| 2023-02-28 | $15.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $27.26M derived: sum of 2 quarters · filed 2024-04-09 | $40.25M 10-Q · filed 2024-04-09 | $52.79M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-11-30 | $12.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | $25.10M 10-Q · filed 2024-01-09 | $37.64M derived: sum of 3 quarters · filed 2024-07-30 | $44.30M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-08-31 | $13.00M 10-Q · filed 2023-10-10 | $25.53M derived: sum of 2 quarters · filed 2024-07-30 | $32.19M derived: sum of 3 quarters · filed 2024-07-30 | $36.13M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-05-31 | $12.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $19.19M derived: sum of 2 quarters · filed 2024-07-30 | $23.13M derived: sum of 3 quarters · filed 2024-07-30 | $24.43M 10-K · filed 2024-07-30 | ||
| 2022-02-28 | $6.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-04 | $10.60M derived: sum of 2 quarters · filed 2023-04-04 | $11.89M 10-Q · filed 2023-04-04 | $19.21M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-11-30 | $3.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $5.24M 10-Q · filed 2023-01-09 | $12.55M derived: sum of 3 quarters · filed 2023-08-15 | $20.86M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-08-31 | $1.29M 10-Q · filed 2022-09-30 | $8.61M derived: sum of 2 quarters · filed 2023-08-15 | $16.91M derived: sum of 3 quarters · filed 2023-08-15 | $23.76M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-05-31 | $7.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15 | $15.62M derived: sum of 2 quarters · filed 2023-08-15 | $22.46M derived: sum of 3 quarters · filed 2023-08-15 | $26.71M 10-K · filed 2023-08-15 | ||
| 2021-02-28 | $8.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-01 | $15.14M derived: sum of 2 quarters · filed 2022-04-01 | $19.39M 10-Q · filed 2022-04-01 | $27.12M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-11-30 | $6.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-30 | $11.09M 10-Q · filed 2021-12-30 | $18.82M derived: sum of 3 quarters · filed 2022-07-27 | $22.34M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-08-31 | $4.25M 10-Q · filed 2021-09-30 | $11.98M derived: sum of 2 quarters · filed 2022-07-27 | $15.49M derived: sum of 3 quarters · filed 2022-07-27 | $21.83M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-05-31 | $7.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | $11.25M derived: sum of 2 quarters · filed 2022-07-27 | $17.58M derived: sum of 3 quarters · filed 2022-07-27 | $24.05M 10-K · filed 2022-07-27 | ||
| 2020-02-29 | $3.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | $9.85M derived: sum of 2 quarters · filed 2021-03-31 | $16.32M 10-Q · filed 2021-03-31 | $19.11M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-11-30 | $6.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-29 | $12.81M 10-Q · filed 2020-12-29 | $15.59M derived: sum of 3 quarters · filed 2021-07-30 | $20.75M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-08-31 | $6.47M 10-Q · filed 2020-09-30 | $9.25M derived: sum of 2 quarters · filed 2021-07-30 | $14.41M derived: sum of 3 quarters · filed 2021-07-30 | $19.21M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-05-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30 | $7.94M derived: sum of 2 quarters · filed 2021-07-30 | $12.74M derived: sum of 3 quarters · filed 2021-07-30 | $14.66M 10-K · filed 2021-07-30 | ||
| 2019-02-28 | $5.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $9.96M derived: sum of 2 quarters · filed 2020-04-03 | $11.88M 10-Q · filed 2020-04-03 | $16.53M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-11-30 | $4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-27 | $6.72M 10-Q · filed 2019-12-27 | $11.37M derived: sum of 3 quarters · filed 2020-07-30 | $17.26M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-08-31 | $1.92M 10-Q · filed 2019-09-26 | $6.57M derived: sum of 2 quarters · filed 2020-07-30 | $12.46M derived: sum of 3 quarters · filed 2020-07-30 | $18.45M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-05-31 | $4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | $10.54M derived: sum of 2 quarters · filed 2020-07-30 | $16.53M derived: sum of 3 quarters · filed 2020-07-30 | $20.95M 10-K · filed 2020-07-30 | ||
| 2018-02-28 | $5.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-29 | $11.88M derived: sum of 2 quarters · filed 2019-03-29 | $16.30M 10-Q · filed 2019-03-29 | $17.87M derived: sum of 4 quarters · filed 2019-07-30 | ||
| 2017-11-30 | $5.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-28 | $10.41M 10-Q · filed 2018-12-28 | $11.98M derived: sum of 3 quarters · filed 2019-07-30 | $18.75M derived: sum of 4 quarters · filed 2019-07-30 | ||
| 2017-08-31 | $4.42M 10-Q · filed 2018-10-05 | $5.99M derived: sum of 2 quarters · filed 2019-07-30 | $12.76M derived: sum of 3 quarters · filed 2019-07-30 | $15.55M derived: sum of 4 quarters · filed 2019-07-30 | ||
| 2017-05-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30 | $8.34M derived: sum of 2 quarters · filed 2019-07-30 | $11.13M derived: sum of 3 quarters · filed 2019-07-30 | $14.58M 10-K · filed 2019-07-30 | ||
| 2017-02-28 | $6.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-29 | $9.56M derived: sum of 2 quarters · filed 2018-03-29 | $13.00M 10-Q · filed 2018-03-29 | $16.08M derived: sum of 4 quarters · filed 2018-07-27 | ||
| 2016-11-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | $6.24M 10-Q · filed 2018-01-05 | $9.31M derived: sum of 3 quarters · filed 2018-07-27 | $12.64M derived: sum of 4 quarters · filed 2018-07-27 | ||
| 2016-08-31 | $3.45M 10-Q · filed 2017-09-29 | $6.52M derived: sum of 2 quarters · filed 2018-07-27 | $9.85M derived: sum of 3 quarters · filed 2018-07-27 | $14.85M derived: sum of 4 quarters · filed 2018-07-27 | ||
| 2016-05-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-27 | $6.41M derived: sum of 2 quarters · filed 2018-07-27 | $11.40M derived: sum of 3 quarters · filed 2018-07-27 | $14.22M 10-K · filed 2018-07-27 | ||
| 2016-02-29 | $3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-31 | $8.32M derived: sum of 2 quarters · filed 2017-03-31 | $11.14M 10-Q · filed 2017-03-31 | $13.90M derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2015-11-30 | $4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-29 | $7.82M 10-Q · filed 2016-12-29 | $10.57M derived: sum of 3 quarters · filed 2017-07-28 | $12.73M derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2015-08-31 | $2.82M 10-Q · filed 2016-09-30 | $5.58M derived: sum of 2 quarters · filed 2017-07-28 | $7.74M derived: sum of 3 quarters · filed 2017-07-28 | $9.93M derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2015-05-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $4.91M derived: sum of 2 quarters · filed 2017-07-28 | $7.11M derived: sum of 3 quarters · filed 2017-07-28 | $9.62M 10-K · filed 2017-07-28 | ||
| 2015-02-28 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-31 | $4.35M derived: sum of 2 quarters · filed 2016-03-31 | $6.86M 10-Q · filed 2016-03-31 | $11.06M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-11-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08 | $4.71M 10-Q · filed 2016-01-08 | $8.90M derived: sum of 3 quarters · filed 2016-07-29 | $11.76M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-08-31 | $2.51M 10-Q · filed 2015-09-30 | $6.71M derived: sum of 2 quarters · filed 2016-07-29 | $9.56M derived: sum of 3 quarters · filed 2016-07-29 | $12.01M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-05-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $7.05M derived: sum of 2 quarters · filed 2016-07-29 | $9.50M derived: sum of 3 quarters · filed 2016-07-29 | $11.54M 10-K · filed 2016-07-29 | ||
| 2014-02-28 | $2.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-01 | $5.31M derived: sum of 2 quarters · filed 2015-04-01 | $7.35M 10-Q · filed 2015-04-01 | $9.27M derived: sum of 4 quarters · filed 2015-07-30 | ||
| 2013-11-30 | $2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-30 | $4.49M 10-Q · filed 2014-12-30 | $6.42M derived: sum of 3 quarters · filed 2015-07-30 | $10.02M derived: sum of 4 quarters · filed 2015-07-30 | ||
| 2013-08-31 | $2.04M 10-Q · filed 2014-09-30 | $3.97M derived: sum of 2 quarters · filed 2015-07-30 | $7.57M derived: sum of 3 quarters · filed 2015-07-30 | $9.02M derived: sum of 4 quarters · filed 2015-07-30 | ||
| 2013-05-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | $5.53M derived: sum of 2 quarters · filed 2015-07-30 | $6.97M derived: sum of 3 quarters · filed 2015-07-30 | $8.90M 10-K · filed 2015-07-30 | ||
| 2013-02-28 | $3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-04 | $5.05M derived: sum of 2 quarters · filed 2014-04-04 | $6.97M 10-Q · filed 2014-04-04 | $6.80M 10-Q · filed 2013-03-28 | $8.56M derived: sum of 4 quarters · filed 2014-07-30 | |
| 2012-11-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-09 | $3.37M 10-Q · filed 2014-01-09 | $4.96M derived: sum of 3 quarters · filed 2014-07-30 | $6.89M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-08-31 | $1.92M 10-Q · filed 2013-09-30 | $3.52M derived: sum of 2 quarters · filed 2014-07-30 | $5.44M derived: sum of 3 quarters · filed 2014-07-30 | $7.51M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-05-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | $3.52M derived: sum of 2 quarters · filed 2014-07-30 | $5.59M derived: sum of 3 quarters · filed 2014-07-30 | $12.41M 10-K · filed 2014-07-30 | ||
| 2012-02-29 | $1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-28 | $3.99M derived: sum of 2 quarters · filed 2013-03-28 | $10.82M 10-Q · filed 2013-03-28 | $13.26M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-11-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-28 | $8.90M 10-Q · filed 2012-12-28 | $11.34M derived: sum of 3 quarters · filed 2013-07-30 | $13.27M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-08-31 | $6.83M 10-Q · filed 2012-09-28 | $9.27M derived: sum of 2 quarters · filed 2013-07-30 | $11.20M derived: sum of 3 quarters · filed 2013-07-30 | $13.05M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-05-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-30 | $4.37M derived: sum of 2 quarters · filed 2013-07-30 | $6.22M derived: sum of 3 quarters · filed 2013-07-30 | $7.80M 10-K · filed 2013-07-30 | ||
| 2011-02-28 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | $3.78M derived: sum of 2 quarters · filed 2012-03-30 | $5.35M 10-Q · filed 2012-03-30 | |||
| 2010-11-30 | $1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | $3.42M 10-Q · filed 2011-12-30 | ||||
| 2010-08-31 | $1.57M 10-Q · filed 2011-09-30 | |||||
| 2010-05-31 | $5.43M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |